Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Huntsworth plc

Market Cap 412M 356M 327M 308M 579M 38.92B 583M 3.88B 1.51B 19.1B 1.55B 1.51B 66.09B P/E 2018
17.7x
P/E 2019 15.1x
Enterprise Value 528M 455M 419M 394M 741M 49.82B 747M 4.96B 1.93B 24.45B 1.98B 1.94B 84.58B EV / Sales 2018
2x
EV / Sales 2019 1.57x
Free-Float
-
Yield 2018
2.13%
Yield 2019 3.19%
Manager TitleAgeSince
Compliance Officer 59 2007-12-31
Director TitleAgeSince
Director/Board Member 42 2019-09-30
Director/Board Member - 2022-02-06
Date Insider Type Main position Quantity % Market Cap.
20-03-26Sell

Director

608,059 0.1643%
20-03-26Fiscal year

Director

1,472,392 0.3978%
20-03-11Sell

Director

56,960 0.0154%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 508M
-2.45%+1.25%-5.91%+20.62% 26.38B
-4.61%-4.31%+4.19%-22.77% 21.75B
-1.54%-5.01%-27.99%-31.64% 10.94B
+19.40%-.--%+12,602.13% - 6.83B
-2.24%+4.46%+33.10%+1.21% 4.85B
-2.38%-5.37%-13.60%+25.68% 4.32B
-4.32%-0.26%-47.60%-68.35% 4.11B
+16.65%+26.60% - - 2.97B
-0.55%-3.75%-18.58%-54.26% 2.65B
Average +1.75%-0.12%+1,565.72%-18.50% 8.53B
Weighted average by Cap. -0.57%+1.22%+1,045.76%-8.07%

Financials

2018 2019
Net sales 225M 194M 178M 168M 316M 21.23B 318M 2.11B 823M 10.42B 844M 826M 36.04B 265M 228M 210M 198M 372M 25B 375M 2.49B 969M 12.27B 994M 973M 42.44B
Net income 21.29M 18.37M 16.89M 15.89M 29.87M 2.01B 30.12M 200M 77.91M 986M 79.91M 78.2M 3.41B 20.3M 17.51M 16.1M 15.15M 28.47M 1.92B 28.71M 191M 74.27M 940M 76.17M 74.55M 3.25B
Net Debt 77M 66.43M 61.07M 57.49M 108M 7.27B 109M 724M 282M 3.57B 289M 283M 12.34B 115M 99.57M 91.55M 86.17M 162M 10.89B 163M 1.08B 422M 5.35B 433M 424M 18.49B
Logo Huntsworth plc
Huntsworth Limited is a United Kingdom-based intermediate holding company. The Company is engaged in healthcare and communication activities. The Company, through its subsidiaries, is focused on health that provides marketing and medical communications services to healthcare clients, which are primarily large and mid-size pharmaceuticals and biotechnology companies. It also provides a range of communications and advisory services, including strategic communications, public affairs, investor relations and consumer marketing. The Company’s financial instruments comprise bank loans, bank overdrafts, loan notes, and cash and short-term deposits. The Company’s geographical areas include the United Kingdom, Europe, the United States and the rest of the world. The Company’s subsidiaries operate in approximately 28 in the United Kingdom and Europe.
Employees
-
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!